23andMe to Present at the Wells Fargo Healthcare Conference
01 sept. 2021 16h05 HE
|
23andMe, Inc.
SUNNYVALE, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that management will be...
23andMe Reports FY2022 First Quarter Financial Results
13 août 2021 07h00 HE
|
23andMe, Inc.
First quarter revenue up 23% over prior yearStrong cash balance of $770 millionContinuing to advance therapeutics portfolio to drive future revenue growth SUNNYVALE, Calif., Aug. 13, 2021 ...
23andMe to Report FY2022 First Quarter Financial Results
29 juil. 2021 07h00 HE
|
23andMe, Inc.
SUNNYVALE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial...
Industry Leaders Join 23andMe Board of Directors
21 juin 2021 08h00 HE
|
23andMe, Inc.
SUNNYVALE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that, following the June 16...
23andMe Successfully Closes its Business Combination with VG Acquisition Corp.
16 juin 2021 17h29 HE
|
23andMe, Inc.
SUNNYVALE, Calif. and NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- 23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose...